Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avner Schlessinger

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Nature Genetics|January 3, 2024
Development of a human genetics-guided priority score for 19,365 genes and 399 drug indicationsÁine Duffy, Ben Omega Petrazzini, David Stein, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
Nature Communications|September 24, 2020
Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicityJ G Coen van Hasselt, Rayees Rahman, Jens Hansen, et al.
Nucleic Acids Research|November 25, 2010
ModBase, a database of annotated comparative protein structure models, and associated resourcesUrsula Pieper, Benjamin M Webb, David T Barkan, et al.
Journal of Medicinal Chemistry|July 27, 2018
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)Huan-Chieh Chien, Claire Colas, Karissa Finke, et al.
Plos Computational Biology|September 14, 2021
Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM ChallengeZhaoping Xiong, Minji Jeon, Robert J Allaway, et al.
Annals of Neurology|January 13, 2019
SLC13A3 variants cause acute reversible leukoencephalopathy and α-ketoglutarate accumulationJoseph P Dewulf, Elsa Wiame, Imen Dorboz, et al.
Nature Structural & Molecular Biology|February 6, 2013
Coordinating the impact of structural genomics on the human α-helical transmembrane proteomeUrsula Pieper, Avner Schlessinger, Edda Kloppmann, et al.
American Journal of Human Genetics|May 23, 2024
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variantsDina Buitrago Silva, Marena Trinidad, Alicia Ljungdahl, et al.
Science Translational Medicine|February 11, 2021
Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategiesSofia B Lizarraga, Li Ma, Abbie M Maguire, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Nature Genetics|January 3, 2024
Development of a human genetics-guided priority score for 19,365 genes and 399 drug indicationsÁine Duffy, Ben Omega Petrazzini, David Stein, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
Nature Communications|September 24, 2020
Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicityJ G Coen van Hasselt, Rayees Rahman, Jens Hansen, et al.
Nucleic Acids Research|November 25, 2010
ModBase, a database of annotated comparative protein structure models, and associated resourcesUrsula Pieper, Benjamin M Webb, David T Barkan, et al.
Journal of Medicinal Chemistry|July 27, 2018
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)Huan-Chieh Chien, Claire Colas, Karissa Finke, et al.
Plos Computational Biology|September 14, 2021
Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM ChallengeZhaoping Xiong, Minji Jeon, Robert J Allaway, et al.
Annals of Neurology|January 13, 2019
SLC13A3 variants cause acute reversible leukoencephalopathy and α-ketoglutarate accumulationJoseph P Dewulf, Elsa Wiame, Imen Dorboz, et al.
Nature Structural & Molecular Biology|February 6, 2013
Coordinating the impact of structural genomics on the human α-helical transmembrane proteomeUrsula Pieper, Avner Schlessinger, Edda Kloppmann, et al.
American Journal of Human Genetics|May 23, 2024
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variantsDina Buitrago Silva, Marena Trinidad, Alicia Ljungdahl, et al.
Science Translational Medicine|February 11, 2021
Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategiesSofia B Lizarraga, Li Ma, Abbie M Maguire, et al.
Pageof 12